share_log

Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink

Dow Jones Newswires ·  Mar 3, 2021 18:16

DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings

(END) Dow Jones Newswires

March 03, 2021 05:16 ET (10:16 GMT)

DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings

(END) Dow Jones Newswires

March 03, 2021 05:16 ET (10:16 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment